In accordance with the Share Benefit Rules, the Company will entrust funds to Mizuho Trust & Banking Co., Ltd. (sub-trustee: Custody Bank of Japan, Ltd.) under a trust for the benefit of a third party ...
Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF) and Hanmi Pharmaceutical Co. Ltd. (“Hanmi”) today announced that Aptose, Hanmi and HS North America Ltd., a wholly owned ...
Lunsumio provides high rates of deep and long-lasting responses in third-line and later follicular lymphoma, a disease that typically becomes harder to treat each time a patient relapses1,2 Lunsumio ...
Copenhagen, Denmark, November 19, 2025, (GLOBE NEWSWIRE) – BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR), today announced interim financial results for the third quarter of 2025, unchanged ...
Live webcasts of the presentations will be accessible on the “ Events ” page of the BBOT website at https://investors.bbotx.com/news-events/events. Replays of the webcasts will be available for at ...
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Piper Sandler 37 th Annual ...
The webcasts of the Jefferies London and Piper Sandler fireside chats can be accessed by visiting the Investors section of ALX Oncology’s website at www.alxoncology.com under the Events section of the ...
Eledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in Investigator-Initiated Trial at ...
Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act. Suja Life is a better-for-you beverage ...
Capsa's central fill and mail-order (CFMO) solutions help health systems operate more efficiently while addressing workforce constraints. By integrating automation with intelligent orchestration ...
NeuroSigma Launches Next-Generation Monarch Device for Pediatric ADHD After Successful Pilot Program
New Website Supports Second-Generation Launch NeuroSigma has launched a new website to support the commercialization of its second-generation Monarch device. The website provides product information ...
SAN FRANCISCO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for disorders of the nervous system, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback